Paul W. Hawran

Chief Financial Officer, Neurocrine Biosciences.

Companies

Plus TherapeuticsBoard member Apr 10, 2006 to Jan 27, 2017¹
SequenomChief financial officer Apr 4, 2007 to Mar 16, 2009²
SequenomBoard member Aug 23, 2006 to Feb 20, 2007³
Neurocrine BiosciencesChief financial officer Jan 23, 2006 to May 18, 2006⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPlus Therapeutics, Board member
2
SEC EDGARSequenom, Chief financial officer
3
SEC EDGARSequenom, Board member
4
SEC EDGARNeurocrine Biosciences, Chief financial officer